XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity and Convertible Preferred Stock (Tables)
9 Months Ended
Sep. 30, 2025
Stockholders’ Equity and Convertible Preferred Stock [Abstract]  
Schedule of Warrant Activity

A summary of warrant activity for the nine months ended September 30, 2025, is presented below:

  

       Weighted       Weighted
Average
Remaining
 
       Average
Exercise
   Total
Intrinsic
   Contractual
Life
 
   Warrants   Price   Value   (in years) 
Outstanding as of December 31, 2024   444,796   $29.25    
-
    1.20 
Granted   7,752,108    3.97    
 
      
Expired   (87,598)  $28.74    
-
    - 
Exercised   (1,173,426)   3.96    
 
      
Outstanding as of September 30, 2025   6,935,880   $5.33    
-
    4.1 
Schedule of Restricted Stock Awards Activity

A summary of restricted stock awards activity for the nine months ended September 30, 2025, is presented below: 

 

   Number of   Weighted 
   Restricted
Stock
Awards
   Average
Grant Day
Fair Value
 
Nonvested at December 31, 2024   50,000   $0.98 
Granted   1,210,969   $6.30 
Vested   (1,210,969)  $6.30 
Forfeited   
-
   $
-
 
Nonvested at September 30, 2025   50,000   $0.98 
Schedule of Option Activity Under the Company’s Stock Option Plan

A summary of option activity under the Company’s stock option plan for the nine months ended September 30, 2025, is presented below:

 

               Weighted 
               Average 
       Weighted   Total   Remaining 
      Average   Intrinsic   Contractual 
   Number of
Shares
   Exercise
Price
   Value
($000s)
   Life
(in years)
 
Outstanding as of December 31, 2024   376,654   $4.29   $
-
    8.2 
Employee options granted   10,000,000   $3.85         9.8 
Employee options exercised   (30,000)   3.36           
Employee options expired   (128,652)  $3.68           
Employee options forfeited   (181,669)  $3.50   $4    - 
Outstanding as of September 30, 2025   10,036,333   $6.18   $9,336    9.4 
Options vested and exercisable   10,021,333   $6.18   $9,330    9.4 
Schedule of Assumptions Used in the Company’s Fair Value Analysis

The following were assumptions used in the Company’s fair value analysis:

 

Risk-free interest rate   4.14%
Estimated maturity date   10 years 
Underlying stock price   6.16 
Expected volatility   112.5%